VIVO Annual Cash & Cash Equivalents
$81.45 M
+$31.68 M+63.66%
30 September 2022
Summary:
As of February 5, 2025, VIVO annual cash & cash equivalents is $81.45 million, with the most recent change of +$31.68 million (+63.66%) on September 30, 2022. During the last 3 years, it has risen by +$19.06 million (+30.54%).VIVO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIVO Quarterly Cash And Cash Equivalents
$81.45 M
-$2.03 M-2.44%
30 September 2022
Summary:
As of February 5, 2025, VIVO quarterly cash and cash equivalents is $81.45 million, with the most recent change of -$2.03 million (-2.44%) on September 30, 2022. Over the past year, it has increased by +$31.68 million (+63.66%).VIVO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIVO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.7% | +63.7% |
| 3 y3 years | +30.5% | +30.5% |
| 5 y5 years | +42.7% | +42.7% |
VIVO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -2.4% |
Meridian Bioscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | $81.45 M(+63.7%) | $81.45 M(-2.4%) |
| June 2022 | - | $83.49 M(+9.2%) |
| Mar 2022 | - | $76.49 M(+5.2%) |
| Dec 2021 | - | $72.73 M(+46.1%) |
| Sept 2021 | $49.77 M(-7.0%) | $49.77 M(-28.9%) |
| June 2021 | - | $70.01 M(+10.5%) |
| Mar 2021 | - | $63.37 M(+0.3%) |
| Dec 2020 | - | $63.19 M(+18.1%) |
| Sept 2020 | $53.51 M(-14.2%) | $53.51 M(-15.7%) |
| June 2020 | - | $63.45 M(+28.0%) |
| Mar 2020 | - | $49.55 M(-27.7%) |
| Dec 2019 | - | $68.56 M(+9.9%) |
| Sept 2019 | $62.40 M(+4.4%) | $62.40 M(+13.1%) |
| June 2019 | - | $55.19 M(-16.5%) |
| Mar 2019 | - | $66.10 M(+7.4%) |
| Dec 2018 | - | $61.52 M(+2.9%) |
| Sept 2018 | $59.76 M(+4.7%) | $59.76 M(+3.2%) |
| June 2018 | - | $57.93 M(+2.7%) |
| Mar 2018 | - | $56.40 M(+3.1%) |
| Dec 2017 | - | $54.71 M(-4.1%) |
| Sept 2017 | $57.07 M(+20.8%) | $57.07 M(+3.3%) |
| June 2017 | - | $55.25 M(+0.9%) |
| Mar 2017 | - | $54.74 M(+11.1%) |
| Dec 2016 | - | $49.28 M(+4.3%) |
| Sept 2016 | $47.23 M(-5.5%) | $47.23 M(+3.1%) |
| June 2016 | - | $45.80 M(-6.4%) |
| Mar 2016 | - | $48.95 M(-8.4%) |
| Dec 2015 | - | $53.42 M(+6.9%) |
| Sept 2015 | $49.97 M(+16.1%) | $49.97 M(+8.7%) |
| June 2015 | - | $45.98 M(+7.6%) |
| Mar 2015 | - | $42.72 M(-13.7%) |
| Dec 2014 | - | $49.52 M(+15.0%) |
| Sept 2014 | $43.05 M(-2.8%) | $43.05 M(+9.6%) |
| June 2014 | - | $39.28 M(+2.8%) |
| Mar 2014 | - | $38.21 M(-12.6%) |
| Dec 2013 | - | $43.73 M(-1.2%) |
| Sept 2013 | $44.28 M(+40.2%) | $44.28 M(+9.7%) |
| June 2013 | - | $40.36 M(+4.6%) |
| Mar 2013 | - | $38.59 M(+16.4%) |
| Dec 2012 | - | $33.15 M(+4.9%) |
| Sept 2012 | $31.59 M(+33.7%) | $31.59 M(+13.1%) |
| June 2012 | - | $27.94 M(+14.8%) |
| Mar 2012 | - | $24.34 M(-7.1%) |
| Dec 2011 | - | $26.20 M(+10.9%) |
| Sept 2011 | $23.63 M(-37.6%) | $23.63 M(-7.6%) |
| June 2011 | - | $25.56 M(-9.9%) |
| Mar 2011 | - | $28.38 M(-31.6%) |
| Dec 2010 | - | $41.48 M(+9.5%) |
| Sept 2010 | $37.88 M(-29.9%) | $37.88 M(-34.9%) |
| June 2010 | - | $58.22 M(+10.3%) |
| Mar 2010 | - | $52.79 M(-9.7%) |
| Dec 2009 | - | $58.46 M(+8.2%) |
| Sept 2009 | $54.03 M(+9.6%) | $54.03 M(+1.1%) |
| June 2009 | - | $53.43 M(+10.6%) |
| Mar 2009 | - | $48.31 M(-2.9%) |
| Dec 2008 | - | $49.76 M(+0.9%) |
| Sept 2008 | $49.30 M(-0.2%) | $49.30 M(+4.8%) |
| June 2008 | - | $47.05 M(+4.5%) |
| Mar 2008 | - | $45.02 M(-7.2%) |
| Dec 2007 | - | $48.51 M(-1.8%) |
| Sept 2007 | $49.40 M(+35.9%) | $49.40 M(+7.4%) |
| June 2007 | - | $46.01 M(+15.2%) |
| Mar 2007 | - | $39.93 M(-5.5%) |
| Dec 2006 | - | $42.26 M(+16.3%) |
| Sept 2006 | $36.35 M(+9.9%) | $36.35 M(+4.7%) |
| June 2006 | - | $34.73 M(+10.9%) |
| Mar 2006 | - | $31.32 M(-6.1%) |
| Dec 2005 | - | $33.34 M(+0.8%) |
| Sept 2005 | $33.09 M | $33.09 M(+721.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2005 | - | $4.03 M(+11.9%) |
| Mar 2005 | - | $3.60 M(-27.8%) |
| Dec 2004 | - | $4.99 M(+151.5%) |
| Sept 2004 | $1.98 M(-26.1%) | $1.98 M(-25.3%) |
| June 2004 | - | $2.66 M(+69.6%) |
| Mar 2004 | - | $1.57 M(-57.8%) |
| Dec 2003 | - | $3.71 M(+38.4%) |
| Sept 2003 | $2.68 M(-12.3%) | $2.68 M(-8.2%) |
| June 2003 | - | $2.92 M(-11.9%) |
| Mar 2003 | - | $3.32 M(-19.9%) |
| Dec 2002 | - | $4.15 M(+35.5%) |
| Sept 2002 | $3.06 M(-34.5%) | $3.06 M(-33.6%) |
| June 2002 | - | $4.61 M(+1.3%) |
| Mar 2002 | - | $4.55 M(-7.2%) |
| Dec 2001 | - | $4.90 M(+4.9%) |
| Sept 2001 | $4.67 M(-2.0%) | $4.67 M(+45.3%) |
| June 2001 | - | $3.22 M(-23.5%) |
| Mar 2001 | - | $4.20 M(-8.5%) |
| Dec 2000 | - | $4.59 M(-3.6%) |
| Sept 2000 | $4.77 M(-23.5%) | $4.77 M(-4.4%) |
| June 2000 | - | $4.98 M(-21.2%) |
| Mar 2000 | - | $6.32 M(-29.8%) |
| Dec 1999 | - | $9.00 M(+44.5%) |
| Sept 1999 | $6.23 M(-67.9%) | $6.23 M(+24.6%) |
| June 1999 | - | $5.00 M(-23.1%) |
| Mar 1999 | - | $6.50 M(+27.5%) |
| Dec 1998 | - | $5.10 M(-73.7%) |
| Sept 1998 | $19.40 M(+84.8%) | $19.40 M(+78.0%) |
| June 1998 | - | $10.90 M(-1.8%) |
| Mar 1998 | - | $11.10 M(0.0%) |
| Dec 1997 | - | $11.10 M(+5.7%) |
| Sept 1997 | $10.50 M(+87.5%) | $10.50 M(-23.4%) |
| June 1997 | - | $13.70 M(-6.8%) |
| Mar 1997 | - | $14.70 M(-7.5%) |
| Dec 1996 | - | $15.90 M(+183.9%) |
| Sept 1996 | $5.60 M(-37.1%) | $5.60 M(-30.0%) |
| June 1996 | - | $8.00 M(-21.6%) |
| Mar 1996 | - | $10.20 M(-3.8%) |
| Dec 1995 | - | $10.60 M(+19.1%) |
| Sept 1995 | $8.90 M(+1.1%) | $8.90 M(-2.2%) |
| June 1995 | - | $9.10 M(+11.0%) |
| Mar 1995 | - | $8.20 M(+5.1%) |
| Dec 1994 | - | $7.80 M(-11.4%) |
| Sept 1994 | $8.80 M(-7.4%) | $8.80 M(+12.8%) |
| June 1994 | - | $7.80 M(+21.9%) |
| Mar 1994 | - | $6.40 M(-34.0%) |
| Dec 1993 | - | $9.70 M(+2.1%) |
| Sept 1993 | $9.50 M(+427.8%) | $9.50 M(+400.0%) |
| June 1993 | - | $1.90 M(+18.8%) |
| Mar 1993 | - | $1.60 M(-5.9%) |
| Dec 1992 | - | $1.70 M(-5.6%) |
| Sept 1992 | $1.80 M(+12.5%) | $1.80 M(+28.6%) |
| June 1992 | - | $1.40 M(-22.2%) |
| Mar 1992 | - | $1.80 M(+125.0%) |
| Dec 1991 | - | $800.00 K(-50.0%) |
| Sept 1991 | $1.60 M(-40.7%) | $1.60 M(-5.9%) |
| June 1991 | - | $1.70 M(-26.1%) |
| Mar 1991 | - | $2.30 M(+4.5%) |
| Dec 1990 | - | $2.20 M(-18.5%) |
| Sept 1990 | $2.70 M(-35.7%) | $2.70 M(+8.0%) |
| June 1990 | - | $2.50 M(+13.6%) |
| Mar 1990 | - | $2.20 M(-46.3%) |
| Dec 1989 | - | $4.10 M(-2.4%) |
| Sept 1989 | $4.20 M(+16.7%) | $4.20 M(+7.7%) |
| June 1989 | - | $3.90 M(+8.3%) |
| Sept 1988 | $3.60 M(-26.5%) | $3.60 M(-26.5%) |
| Sept 1987 | $4.90 M(-16.9%) | $4.90 M(-16.9%) |
| Sept 1986 | $5.90 M(+742.9%) | $5.90 M(+742.9%) |
| Sept 1985 | $700.00 K | $700.00 K |
FAQ
- What is Meridian Bioscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Meridian Bioscience?
- What is Meridian Bioscience annual cash & cash equivalents year-on-year change?
- What is Meridian Bioscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Meridian Bioscience?
- What is Meridian Bioscience quarterly cash and cash equivalents year-on-year change?
What is Meridian Bioscience annual cash & cash equivalents?
The current annual cash & cash equivalents of VIVO is $81.45 M
What is the all time high annual cash & cash equivalents for Meridian Bioscience?
Meridian Bioscience all-time high annual cash & cash equivalents is $81.45 M
What is Meridian Bioscience annual cash & cash equivalents year-on-year change?
Over the past year, VIVO annual cash & cash equivalents has changed by +$31.68 M (+63.66%)
What is Meridian Bioscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VIVO is $81.45 M
What is the all time high quarterly cash and cash equivalents for Meridian Bioscience?
Meridian Bioscience all-time high quarterly cash and cash equivalents is $83.49 M
What is Meridian Bioscience quarterly cash and cash equivalents year-on-year change?
Over the past year, VIVO quarterly cash and cash equivalents has changed by +$31.68 M (+63.66%)